Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing

Chan Gyu Lee(Insilicogen (South Korea)), Young Kee Shin(Seoul National University of Science and Technology)
Frontiers in Pharmacology
January 8, 2021
Cited by 12


Related Papers